VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.2564
+0.0035 (1.38%)
Sep 29, 2026, 3:41 PM EDT - Market open
VolitionRx Employees
VolitionRx had 57 employees as of June 30, 2026. The number of employees decreased by 13 or -18.57% compared to the same quarter last year.
Employees
57
Change
-13
Growth
-18.57%
Revenue / Employee
$43,124
Profits / Employee
-$457,897
Market Cap
3.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 57 | -13 | -18.57% | 57 | 0 |
| Mar 31, 2026 | 67 | -15 | -18.29% | 67 | 0 |
| Dec 31, 2025 | 75 | -10 | -11.76% | 75 | 0 |
| Sep 30, 2025 | 75 | -21 | -21.88% | 75 | 0 |
| Jun 30, 2025 | 70 | -31 | -30.69% | 70 | 0 |
| Mar 31, 2025 | 82 | -26 | -24.07% | 82 | 0 |
| Dec 31, 2024 | 85 | -25 | -22.73% | 85 | 0 |
| Sep 30, 2024 | 96 | -18 | -15.79% | 96 | 0 |
| Jun 30, 2024 | 101 | -10 | -9.01% | 101 | 0 |
| Mar 31, 2024 | 108 | 4 | 3.85% | 108 | 0 |
| Dec 31, 2023 | 110 | 6 | 5.77% | 110 | 0 |
| Sep 30, 2023 | 114 | 15 | 15.15% | 114 | 0 |
| Jun 30, 2023 | 111 | 12 | 12.12% | 111 | 0 |
| Dec 31, 2022 | 104 | 21 | 25.30% | 104 | 0 |
| Jun 30, 2022 | 99 | - | - | 99 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vivos Therapeutics | 270 |
| WORK Medical Technology Group LTD | 238 |
| Intelligent Bio Solutions | 60 |
| Beyond Air | 54 |
| INVO Fertility | 42 |
| Adagio Medical Holdings | 41 |
| Nuwellis | 38 |
| Autonomix Medical | 11 |
VNRX News
- 12 days ago - VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - PRNewsWire
- 12 days ago - VolitionRx Participates in Launch of DETECSEPS Program in France - PRNewsWire
- 15 days ago - VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - PRNewsWire
- 19 days ago - VolitionRx presents early stage I solid cancer detection at ESMO MAP Conference - TheFly
- 19 days ago - Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference - PRNewsWire
- 19 days ago - VolitionRx Slides: Corporate presentation - Filings
- 20 days ago - VolitionRx Registration statement: Registration filing - Filings
- 21 days ago - VolitionRx Registration statement: Registration filing - Filings